Orphazyme elects new board member

At an extraordinary general meeting on Tuesday, biotech firm Orphazyme elected a new board member, Andrew Mercieca.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme makes changes to board of directors
For subscribers
Orphazyme gets investor backing for fundraising round
For subscribers
Orphazyme plans to resubmit FDA application in H2
For subscribers